Agrin as a Stable Biomarker for Muscle Strength Decline in Elderly Sarcopenic Patients Associated with Neuromuscular Junction Dysfunction
Rejuvenation Research · 01.06.2026 · 29 (3) · 123-130
DOI: 10.1177/15491684251410100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rejuvenation Research, online erschienen am 09.01.2026. Verfasst von Jihai Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Clinical Department of Geriatric Medicine, Department of Geriatric, Geriatric Hospital of Nanjing Medical University, Nanjing, PR China. Hauptthemen laut MEDLINE: Agrin, Sarcopenia, Neuromuscular Junction, Muscle Strength. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: The Jiangsu Health Commission Foundation of China.
Abstract (Originalsprache)
Agrin-mediated neuromuscular junction (NMJ) morphological alterations is one of the main pathogeneses of sarcopenia. The aim of this study was to observe the changes in serum agrin in patients with different degrees of sarcopenia and the alterations in Agrin receptors in human skeletal muscle with age. A total of 236 elderly subjects were enrolled and categorized into nonsarcopenia, possible sarcopenia, sarcopenia, and severe sarcopenia groups. Serum levels of the C-terminal Agrin fragment were quantified using an Enzyme-Linked Immunosorbent Assay (ELISA) kit. In addition, in a distinct and smaller exploratory subgroup ( n = 12), quantitative real-time polymerase chain reaction and immunofluorescence staining were performed to investigate the expression of Agrin receptors, specifically low-density lipoprotein receptor-related protein 4 (Lrp4) and alpha-dystroglycan (α-DG), in human skeletal muscle samples. Compared with that in the nonsarcopenia group, the level of agrin in the other groups was significantly different. Partial correlation analysis and binary logistic regression analysis suggested that the level of Agrin was associated with handgrip strength. There was a significant increase in the serum level of agrin and a reduction in the mRNA expression of the agrin receptors Lrp4 , α-DG, and RAPSN , while immunofluorescence analysis confirmed the expression patterns of the Lrp4 and α-DG receptors. In the elderly population, the level of agrin decreased in patients with sarcopenia, while the expression of its receptors also decreased. These factors result in NMJ morphological alterations, weakened muscle contraction, and increased risk of sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Clinical Department of Geriatric Medicine, Department of Geriatric, Geriatric Hospital of Nanjing Medical University, Nanjing, PR China.
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing, PR China.
Förderung
- The Jiangsu Health Commission Foundation of China
Zitieren
APA
Chen, J., Cheng, N., Liu, Y., Xu, T., Xi, L., Wang, C., & Ouyang, X. (2026). Agrin as a Stable Biomarker for Muscle Strength Decline in Elderly Sarcopenic Patients Associated with Neuromuscular Junction Dysfunction. Rejuvenation Research, 29(3), 123-130. https://doi.org/10.1177/15491684251410100
Vancouver
Chen J, Cheng N, Liu Y, Xu T, Xi L, Wang C, et al. Agrin as a Stable Biomarker for Muscle Strength Decline in Elderly Sarcopenic Patients Associated with Neuromuscular Junction Dysfunction. Rejuvenation Research. 2026;29(3):123-130. doi:10.1177/15491684251410100
BibTeX
@article{Chen2026,
author = {Chen, Jihai and Cheng, Nuo and Liu, Ye and Xu, Tongtong and Xi, Ling and Wang, Cong and Ouyang, Xiaojun},
title = {Agrin as a Stable Biomarker for Muscle Strength Decline in Elderly Sarcopenic Patients Associated with Neuromuscular Junction Dysfunction},
journal = {Rejuvenation Research},
year = {2026},
volume = {29},
number = {3},
pages = {123--130},
doi = {10.1177/15491684251410100}
}
EUVIMED